In this data analysis from two prospective randomized clinical trials, statin and vitamin D use was associated with superior overall survival in men with metastatic CRPC who were treated with Zytiga and prednisone.
Hormone Therapies Benefit Black Men More Than White Men
Palliative Care - Improving Quality of Life and Your Survival
Ablative Radiation Increases Survival in Some Newly Diagnosed Men with Metastatic Prostate Cancer
Men Diagnosed with Advanced Prostate Cancer Have a Longer Survival if They Have Surgery Followed by Radiation
One of the on-going debates surrounds the question, should men with newly diagnosed advanced prostate cancer have a radical prostatectomy (RP). In a retrospective study, it was found that men lived longer if they had an RP followed by adjuvant radiotherapy (XRT). The study was reported in, Cancer, a very reputable Journal.
The Truth About Provenge
African American Men Might Have a Survival Advantage Over Caucasian Men!
Choosing Docetaxel or Zytiga
Confirming The Value of Early Docetaxel in Men With Metastatic Hormone-Sensitive Prostate Cancer
Two Studies Released At ASCO Demonstrate A Survival Advantage For Men Who Take Early Zytiga With ADT
Two game changing trials demonstrated that the early use of Zytiga along with hormone therapy (ADT) can provide a significant survival advantage for men with aggressive, hormone naive prostate cancer. The data is very clear for men with metastatic disease, but there remains some controversy if this holds up for men who are not metastatic.
